Registro:

Referencias:

• Barrett, M.P., Burchmore, R.J., Stich, A., The trypanosomiasis (2003) Lancet, 362 (9394), pp. 1469-1480
• WHO World Health Org Tech rep Ser. 2002; 905: i-vi, 1-109; Dias, J.C., Silveira, A.C., Schofield, C.J., The impact of Chagas disease control in Latin America: A review (2002) Mem Inst Oswaldo Cruz, 97 (5), pp. 603-612
• Schmunis, G.A., Cruz, J.R., Safety of the blood supply in Latin America (2005) Clin Microbiol Rev, 18 (1), pp. 12-29
• (1984) Epidemiologic bulletin, , Panamerican Health Organization Status of Chagas disease in the region of Americas, Pan American Health Organization, Washington, DC
• Matsumoto, S.C., Labovsky, V., Roncoroni, M., Retinal dysfunction in patients with chronic Chagas disease is associated to anti- Trypanosoma cruzi antibodies that cross-react with rhodopsin (2006) FASEB J, 20 (3), pp. 550-552
• Tarleton, R.J., Parasite persistence in the aetiology of Chagas disease (2001) Int J Parasitol, 31 (5-6), pp. 550-554
• Riveiro dos Santos, G., Nishiya, A.S., Sabino, E.C., Chamone, D.F., Saez-Alquezar, A., An improved PCR-based strategy for the detection of Trypanosoma cruzi in human blood samples (1999) Ann Trop Med Parasitol, 93 (7), pp. 689-694
• Manawa, E.S., Bastos, S.F., Camargo, M.E., Evaluation of recombinant antigens for serodiagnosis of Chagas disease in South and Central America (1999) J Clin Microbiol, 37 (5), pp. 1554-1560
• Hernandez Marin, M., Hernandez Spengler, I., Ramos Martinez, G., Pozo Pena, L., Chimeric synthetic peptides as antigens for detection of antibodies to Trypanosoma cruzi (2006) Biochem Biophys Res Commun, 339 (1), pp. 89-92
• Rodríguez Coura, J., de Castro, S.L., A critical review on Chagas disease chemotherapy (2002) Mem Inst Oswaldo Cruz, 97 (1), pp. 3-24
• Garcia, S., Ramos, C.O., Senra, J.F.V., Treatment with benznidazole during the chronic phase of experimental Chagas disease decreases cardiac alterations (2005) Antimicrob Agents and Chemother, 49 (4), pp. 1521-1528
• Apt, W., Arribada, A., Zulantay, I., Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: The results of clinical and parasitological examinations 11 years post-treatment (2005) Ann Trop Med Parasitol, 99 (8), pp. 733-741
• Fournet, A., Munoz, V., Natural products as trypanocidal, antileishmanial and antimalarial drugs (2002) Curr Top Med Chem, 2 (11), pp. 1215-1237
• Morel, C.M., Neglected diseases: Under-funded research and inadequate health interventions. Can we change this reality? (2003) EMBO Rep, 4, pp. 35-38
• Morel, C.M., Acharya, T., Broun, D., Health innovation networks to help developing countries address neglected diseases (2005) Science, 309 (5733), pp. 401-404
• El-Sayed, N.M., Myler, P.J., Bartholomeu, D.C., The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease (2005) Science, 309 (5733), pp. 409-415
• Nguyen, B., Lee, M.P., Hamelberg, D., Strong binding in the DNA minor groove by an aromatic diamidine with a shape that does not match the curvature of the groove (2002) J Am Chem Soc, 124, pp. 13680-13681
• Hannon, G.J., RNA interference (2002) Nature, 418, pp. 244-251
• Denli, A.M., Hannon, G.J., RNAi: An ever-growing puzzle (2003) Trends Biochem Sci, 28 (4), pp. 196-201
• Cazzulo, J.J., Proteinases of Trypanosoma cruzi: Potential targets for the chemotherapy of Chagas disease (2002) Curr Top Med Chem, 2 (11), pp. 1261-1271
• Cazzulo, J.J., Cazzulo Franke, B.M., Martinez, J., Franke de Cazzulo, B.M., Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi (1990) Biochim Byophys Acta, 1037 (2), pp. 186-191
• Eakin, A.E., Mills, A.A., Harth, G., McKerrow, J.H., Craik, C.S., The sequence, organization, and expression of the major cysteine proteinase (cruzain) from Trypanosoma cruzi (1992) J Biol Chem, 267, pp. 7411-7420
• Murta, A.C.M., Persechini, P.M., de Souto Padrón, T., de Souza, W., Guimaraes, J.A., Scharfstein, J., Structural and functional identification GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase (1990) Mol Biochem Parasitol, 43, pp. 27-38
• Cazzulo, J.J., Labriola, C., Parussini, F., Duschak, V.G., Martinez, J., Franke de Cazzulo, B.M., Cysteine proteinases in Trypanosoma cruzi and other trypanosomatid parasites (1995) Acta Chimica Slovenica, 42, pp. 409-418
• Parusini, F., Duschak, V.G., Cazzulo, J.J., Membrane-bound cysteine proteinase isoforms in different developmental stages of Trypanosoma cruzi (1998) Cell Mol Biol, 44 (3), pp. 513-519
• Duschak, V.G., Barboza, M., Garcia, G.A., Lammel, E.M., Couto, A.S., Isola, E.L., Novel cysteine proteinase in Trypanosoma cruzi metacyclogenesis (2006) Parasitology, 132 (3), pp. 345-355
• Cazzulo, J.J., Stoka, V., Turk, V., The major cysteine proteinase of Trypanosoma cruzi: A valid target for chemotherapy of Chagas disease (2001) Curr Pharm Des, 7 (12), pp. 1143-1156
• Duschak, V.G., Ciaccio, M., Nassert, J.R., Basombrio, M.A., Enzymatic activity, protein expression, and gene sequence of cruzipain in virulent and attenuated Trypanosoma cruzi strains (2001) J Parasitol, 87 (5), pp. 1016-1022
• Ramos, A.M., Duschak, V.G., Gerez de Burgos, N.M., Trypanosoma cruzi: Cruzipain and membrane-bound cysteine proteinase isoform(s) interacts with human alpha (2)-macroglobulin and pregnancy zone protein (2002) Exp Parasitol, 100 (2), pp. 121-130
• Duschak, V.G., Riarte, A., Segura, E.L., Laucella, S.A., Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease (2001) Immunol Lett, 78 (3), pp. 135-142
• Barboza, M., Duschak, V.G., Cazzulo, J.J., Lederkremer, R.M., Couto, A.S., Presence of sialic acid in N-linked oligosaccharide chains and O-linked N-acetylglucosamine in cruzipain, the major cysteine proteinase of Trypanosoma cruzi (2003) Mol Biochem Parasitol, 126, pp. 293-296
• Barboza, M., Duschak, V.G., Fukuyama, Y., Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides (2005) FEBS J, 272 (15), pp. 3803-3815
• Harth, G., Andrews, N., Mills, A.A., Engel, J.C., Smith, R., McKerrow, J.H., Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi (1993) Mol Biochem Parasitol, 58 (1), pp. 17-24
• Duschak, V.G., Barboza, M., Couto, A.S., Trypanosoma cruzi: Partial characterization of minor cruzipain isoforms non-adsorbed to Concanavalin A-Sepharose (2003) Exp Parasitol, 104 (3-4), pp. 122-130
• McGrath, M.E., Eakin, A.E., Engel, J.C., The crystal structure of cruzain: A therapeutic target for Chagas disease (1995) J Mol Biol, 247 (2), pp. 251-259
• Huang, L., Brinen, L.S., Ellman, J.A., Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain (2003) Bioorg Med Chem, 11 (1), pp. 21-29
• Burleigh, B.A., Caler, E.V., Webster, P., Andrews, N.W., A cytosolic serine endopeptidase from Trypanosoma cruzi is required for the generation of Ca2+ signaling in mammalian cells (1997) J Cell Biol, 136 (3), pp. 609-620
• Morty, R.E., Shih, A.Y., Fulop, V., Andrews, N.W., Identification of the reactive cysteine residues in oligopeptidase B from Trypanosoma brucei (2005) FEBS Lett, 579 (10), pp. 2191-2196
• Lalmanach, G., Mayer, R., Serveau, C., Scharfstein, J., Gauthier, F., Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: Targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi (1996) Biochem J, 318, pp. 395-399
• Hernandez, A.A., Roush, W.R., Recent advances in the synthesis, design and selection of cysteine protease inhibitors (2002) Curr Opin Chem Biol, 6 (4), pp. 459-465
• Engel, J.C., Doyle, P.S., Hsieh, Y., McKenow, J.H., Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection (1998) J Exp Med, 88 (4), pp. 725-734
• Engel, J.C., Doyle, P.S., Palmer, J., Bainton, D.F., Hsieh, I., McKerrow, J.H., Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi (1998) J Cell Sci, 11, pp. 597-606
• McKerrow, J.H., Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action (1999) Int J Parasitol, 29 (6), pp. 833-837
• Roush, W.R., Cheng, J., Knapp-Reed, B., Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain (2001) Bioorg Med Chem Lett, 11, pp. 2759-2762
• Gotz, M.G., Caffrey, C.R., Hansell, E., Mc Kerrow, J.H., Powers, J.C., Peptidyl allyl sulfones: A new class of inhibitors for clan CA cysteine proteases (2004) Bioorg Med Chem, 12 (19), pp. 5203-5211
• Li, R., Chen, X., Gong, B., Structure-based design of parasitic protease inhibitors (1996) Bioorg Med Chem, 4 (9), pp. 1421-1427
• Du, X., Hansell, E., Engel, J.C., Caffrey, C.R., Cohen, F.E., McKerrow, J.H., Aryl ureas represent a new class of anti-trypanosomal agents (2000) Chem Biol, 7 (9), pp. 733-742
• Huang, L., Lee, A., Ellman, J.A., Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis (2002) J Med Chem, 45 (3), pp. 676-684
• Choe, Y., Brinen, L.S., Price, M.S., Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease (2005) Bioorg Med Chem, 13 (6), pp. 2141-2156
• Marquis, R.W., Ru, Y., Veber, D.F., Cummings, M., Thompson, S.K., Yamashita, D.: WO0195911 (2001); Quibell, M., Taylor, S., Grabowska, U., Nilsson, M., Morrison, V., (2002) WO0240462A2 and WO0240462A3
• Quibell, M., Ramjee, M.K: WO02057246A2 and WO02057246A3 (2002); Quibell, M.: WO02057248A2 and WO02057248A3 (2002), WO02057249A1 (2002), WO02057270A1 (2002), CA2436462AA (2002); Quibell, M.: EP1362052A1 (2003), NO20033220A (2003), NO20033220A0 (2003); Quibell, M.: CN1486320A (2004), MX3006224A (2004), ZA0305259A (2004). NZ0526913A (2004); Quibell, M.: Ray, P.C., Watts, J.P.: WO04007501A1 (2004); Lim-Wilb, M., Semple, J.E., Araldi, G.L., Goldman, E.A., Weinhouse, M.I.: WO0248097A1, WO0248097B1 and WO0248097C2 (2002); Quibell, M., Ramjee, M.K., (2005), US20056958358; Marquis, R.W.Jr., Veber, D.F., Yamashita, D.S.: WO03053331A2 and WO03053331A3 (2003); Jeong, J.U., Yamashita, D.S.: WO03103574A2 and WO03103574A3 (2003); WO03104257A2 and WO03104257A3 (2003); WO03097593A2 and WO03097593A3 (2003); Tew, D.G., Thompson, S.K., Veber, D.F.: WO00217924A1 (2002); Altman, E., Betschart, C., Hayakawa, K., Irie, O., Sakaki, J., Iwasaki, G., Lattmann, R., Missbach, M., Teno, N.: WO04020441A1 (2004); Bondebjerg, J., Fuglsang, H., Naerum, L.:WO04110988A1 (2004); Hickey, E.R., Bekkali, Y., Patel, U.R., Spero, D.M., Thomson, D.S., Young, E.R.: WO02100849A2 and WO02100849A3 (2002); Hickey, E.R., Bekkali, Y., Patel, U.R., Spero, D.M., Thomson, D.S., Young, E.R., (2000), US20066982263; Sulea, T., Purisima, E.O., Menard, R., Wang, J.: WO03097664A2 and WO03097664A3 (2003); Du, X., Guo, C., Hartsell, E., Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain (2002) J Med Chem, 45 (13), pp. 2695-2707
• Chibale, K., Musonda, C.C., The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors (2003) Curr Med Chem, 10 (18), pp. 1863-1889
• Chiyanzu, I., Hansell, E., Gut, J., Roshenthal, P.J., McKerrow, J.H., Chibale, K., Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain (2003) Bioorg Med Chem Lett, 13 (20), pp. 3527-3530
• Fujii, N., Mallari, J.P., Hansell, E.J., Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain (2005) Bioorg Med Chem Lett, 15 (1), pp. 121-123
• Yong, V., Schmidtz, V., Vannier-Santos, M.A., Altered expressionof cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases (2000) Mol Biochem Parasitol, 109 (1), pp. 47-59
• Engel, J.C., Garcia, C.T., Hsieh, I., Doyle, P.S., McKerrow, J.H., Upregulation of the secretory pathway in cysteine protease inhibitor-resistant Trypanosoma cruzi (2000) J Cell Sci, 113, pp. 1345-1354
• Desai, P.V., Patny, A., Sabnis, Y., Identification of novel parasitic cysteine protease inhibitors using virtual screening 1. The Chem Bridge database (2004) J Med Chem, 47 (26), pp. 6609-6615
• Barr, S.C., Warner, K.L., Kornreic, B.G., A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi (2005) Antimicrob Agents Chemother, 49 (12), pp. 5160-5161
• Greenbaun, D.C., McMackey, Z., Hansell, E., Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi (2004) J Med Chem, 47 (12), pp. 3212-3229
• Leite, A.C., de Lima, R.S., Moreira, D.R., Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against T. cruzi (2006) Bioorg Med Chem, 14 (11), pp. 3749-3757
• Cohen, F.E., Du, X., Guo, C., McKerrow, J.H., (2005), US20056897240; García, M.P., Nóbrega, O.T., Teixeira, A.R.L., Sousa, M.V., Santana, J.M., Characterization of a Trypanosoma cruzi acidic 30 kDa cysteine protease (1998) Mol Biochem Parasitol, 91, pp. 263-272
• Burleigh, B.A., Andrews, N., A 120-kDa alkaline peptidase from Trypanosoma cruzi is involved in the generation of a novel Ca2+ - signaling factor for mammalian cells (1995) J Biol Chem, 270 (10), pp. 5172-5180
• Santana JM, Grellier P, Schrevel J, Teixeira AR. A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV. Biochem J 1997; 325(1):129-37; Vendeville, S., Bourel, L., Davioud-Charvet, E., Grellier, P., Deprez, B., Sergheraert, C., Automated parallel synthesis of a tetrahydroisoquinolin-based library: Potential prolyl endopeptidase inhibitors (1999) Bioorg Med Chem Lett, 9, pp. 437-442
• Joyeau, R., Maoulida, C., Guillet, C., Synthesis and activity of pyrrolidinyl- and thiazolinidyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from T. cruzi (1999) Eur J Med Chem, 35, pp. 257-266
• Grellier, P., Vendeville, S., Joyeau, R., Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes (2001) J. Biol Chem, 276, pp. 47078-47086
• Bal, G., Van der Veken, P., Antonov, D., Prolylisoxazoles: Potent inhibitors of prolyloligopetidase with antitrypanosomal activity (2003) Bioorg Med Chem Lett, 13 (17), pp. 2875-2878
• Bastos, I.M., Grellier, P., Martins, N.F., Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells (2005) Biochem J, 338 (1), pp. 29-38
• Cuevas, I.C., Cazzulo, J.J., Sanchez, D., GP63 homologues in Trypanosoma cruzi: Surface antigens with metalloprotease activity and a possible role in host cell infection (2003) Infect Immun, 71 (10), pp. 5739-5749
• Paugam, A., Bulteau, A.L., Dupuoy-Camet, J., Creuzet, C., Friguet, B., Characterization and role of protozoan parasite proteasomes (2003) Trends Parasitol, 19 (2), pp. 55-59
• Gonzalez, J., Ramalho-Pinto, F.J., Frevert, U., Proteasome activity is required for the stage-specific transformation of a protozoan parasite (1996) J Exp Med, 184 (5), pp. 1909-1918
• de Diego, J.L., Katz, J.M., Marshall, P., The ubiquintin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling (2001) Biochemistry, 40 (4), pp. 1053-1062
• Palladino, M., Neuteboom, S.T.C., Macherla, V.R.R., Potts, B.C.: WO2005002572A2 and WO2005002572A3 (2005); Steverding, D., Spackman, R.W., Royle, H.J., Glenn, R.J., Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors (2005) Parasitol Res, 95 (1), pp. 73-76
• Schaller, H., (2003) The role of sterols in plant growth and development Prog Lipid Res, 42 (3), pp. 163-175
• Roberts, C.W., McLeod, R., Rice, D.W., Ginger, M., Chance, M.L., Goad, L.J., Fatty acid and sterol metabolism: Potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa (2003) Mol Biochem Parasitol, 126 (2), pp. 129-142
• Quinones, W., Urbina, J.A., Dubourdieu, M., Luis Conception, J., The glycosome membrane of Trypanosoma cruzi epimastigotes: Protein and lipid composition (2004) Exp Parasitol, 106, pp. 135-149
• Braga, M.V., Urbina, J.A., de Souza, W., Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi (2004) Int J Antimicrob Agents, 24 (1), pp. 72-78
• Garzoni, L.R., Caldera, A., Meirelles, M.N., Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi (2004) Int J Antimicrob Agents, 3, pp. 273-285
• Urbina, J.A., Chemotherapy of Chagas' disease: The how and the why (1999) J Mol Med, 77 (3), pp. 332-338
• Urbina, J.A., Payares, G., Contreras, L.M., Antiproliferative effects and mechanism of action of SCH56592 against Trypanosoma cruzi: In vitro and in vivo studies (1998) Antimicrob Agents Chemother, 42, pp. 1771-1777
• Urbina, J.A., Lira, R., Visbal, G., Bartroli, J., in vitro Antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi (2000) Antimicrob Agents Chemother, 44 (9), pp. 2498-2502
• Urbina, J.A., Chemotheraphy of Chagas disease (2002) Curr Pharm Des, 8 (4), pp. 287-295
• Urbina, J.A., Payares, G., Sanoja, C., Lira, R., Romanha, A.J., In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease (2003) Int J Antimicrob Agents, 21 (1), pp. 27-38
• Urbina, J.A., Payares, G., Molina, J.T., Cure of short-and long-term experimental Chagas disease using D0870 (1996) Science, 273, pp. 969-971
• Urbina, J.A., Payares, C., Sanoja, Parasitological cure of acute and chronic experimental Chagas disease using a long-acting experimental triazole TAK-187. Acitivity against drug-resistant Trypanosoma cruzi strains (2003) Int J Antimicrob Agents, 21, pp. 39-48
• Docampo, R., Schmunis, G.A., Sterol biosynthesis inhibitors: Potential chemotherapeutics against Chagas disease (1997) Parasitol Today, 13, pp. 129-130
• Lepesheva GI, Waterman CYP51-the omnipotent P450. Mol Cell Endocrinol 2004; 215: 165-70; Lepesheva, G.I., Zaitzeva, N.G., Nes, W.D., CYP51 from Trypanosoma cruzi: A phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase (2006) J Biol Chem, 281 (6), pp. 3577-3585
• Hanskins, E.G., Gillespie, J.R., Aikenhead, K., Buckner, F.S., Upregulation of sterol C14-demethylase expression in Trypanosoma cruzi treated with sterol biosynthesis inhibitors (2005) Mol Biochem Parasitol, 144 (1), pp. 68-75
• Urbina, J.A., Docampo, R., Specific chemotherapy of Chagas disease: Controversies and advances (2003) Trends Parasitol, 19, pp. 495-501
• Apt, W., Aguilera, Y., Arribada, A., Treatment of chronic Chagas' disease with itraconazole and allopurinol (1998) Am J Trop Med Hyg, 59, pp. 133-138
• Guedes, P.M.M., Urbina, J.A., Lana, M., Activity of the new derivative Albuconazole against Trypanosoma cruzi in dog hosts (2004) Antimicrob Agents Chemoter, 48 (11), pp. 4286-4292
• Buckner, F.S., Wilson, A.J., White, T.C., Van Vooris, W.C., Induction of resistance to azole drugs in Trypanosoma cruzi (1998) Antimicrob Agents Chemother, 42 (12), pp. 3245-3250
• Buckner, F., Yokoyama, K., Lockman, J., A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents (2003) Proc Natl Acad Sci USA, 100 (25), pp. 15149-15153
• Hucke, O., Gelb, M.H., Verlinde, C.L., Buckner, F.S., The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease (2005) J Med Chem, 48 (17), pp. 5415-5418
• Benaim, G., Sanders, J.M., Garcia-Marchan, Y., Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole (2006) J Med Chem, 49 (3), pp. 892-899
• Jouvert, B.M., Buckner, F.S., Matsuda, S.P., Trypanosome and animal lanosterol synthases use different catalytic motifs (2001) Org Lett, 14, pp. 1957-1960
• Rose, I.C., Sharpe, B.A., Lee, R.C., Design, synthesis and in vitro evaluation of pyridinium ion based cyclase inhibitors and antifungal agents (1996) Bioorg Med Chem, 4, pp. 97-103
• Buckner, F.S., Griffin, J.H., Wilson, A.J., Van Voorhis, W.C., Potent anti- Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors (2001) Antimicrob Agents Chemother, 45 (4), pp. 1210-1215
• Oliaro-Bosso, S., Ceruti, M., Balliano, G., Milla, P., Rocco, F., Viola, F., Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae (2005) Lipids, 40 (12), pp. 1257-1262
• Prestwich, G.D., Buckner, F.S., Hinshaw, J.C.: WO0076316A1 (2000); Abe, I., Prestwich, G.D., (1999) Comprehensive natural products chemistry, 2 (10), pp. 267-298. , Cane DE Ed, New York, Elsevier
• Urbina, J.A., Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites (1997) Parasitology, 114, pp. 91-99
• Urbina, J.A., Concepcion, J.L., Rangel, S., Visbal, G., Lira, R., Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana (2002) Mol Biochem Parasitol, 125 (1-2), pp. 35-45
• Urbina, J.A., Concepcion, J.L., Caldera, A., in vitro and in vivo Activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi (2004) Antimicrob Agents Chemother, 48 (7), pp. 2379-2387
• Szajnman, S.H., Yan, W., Bayley, B.N., Docampo, R., Elhalem, E., Rodriguez, J.B., Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation (2000) J Med Chem, 43 (9), pp. 1826-1840
• Elhalem, E., Bailey, B.N., Docampo, R., Ujvary, I., Szajnman, S.H., Rodriguez, J.B., Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi (2002) J Med Chem, 45 (18), pp. 3984-3999
• Urbina, J.A., Concepcion, J.L., Montalvetti, A., Rodriguez, J.B., Docampo, R., Mechanism of action of 4-phenoxyphenoxyethyl thiocyanate (WC-9) against Trypanosoma cruzi, the causative agent of Chagas' disease (2003) Antimibrob Agents Chemoter, 47 (6), pp. 2047-2050
• Hiyoshi, H., Yanagimachi, M., Ito, M., Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes (2003) J Lipid Res, 44 (1), pp. 128-135
• Orenes, L.S., Gomez, R., Jimenez, C., Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa (2005) Bioorg Med Chem, 13 (10), pp. 3519-3529
• Orenes Lorente, S., Jimenez, C.J., Gros, L., Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasitics (2005) Bioorg Med Chem, 13 (18), pp. 5435-5453
• Urbina, J.A., Lazardi, Y., Marchan, E., Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma cruzi: In vitro and in vivo studies (1993) Antimicrob Agents Chemoter, 37 (3), pp. 580-591
• Yardley, V., Crof, S.L., In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections (1999) Am J Trop Med Hyg, 61 (2), pp. 193-197
• Hamilton, A.D., Van Vooris, W.C., Yokoyama, K., Buckner, F.S., Ohkanda, J., Gelb, M.: WO03006012A1 (2003); Lockman J., Hamilton, A.D., Gelb, M., Buckner, F.S., Ohkanda, J., Yokoyama, K., Van Vooris, W.C., CA2453396AA (2003); Hamilton, A.D., Van Vooris, W.C., Yokoyama, K., Buckner, F.S., Ohkanda, J., Gelb, M., Lockman J: BR0211098A (2004); Montalvetti, A., Bailey, B.N., Martin, M.B., Severin, G.W., Oldfield, E., Docampo, R., Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase (2001) J Biol Chem, 276 (36), pp. 33930-33937
• Martin, M.B., Grimley, J.S., Lewis, J.C., Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosonta cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: A potential route to chemotherapy (2001) J Med Chem, 44 (6), pp. 909-916
• Garzoni, L.R., Caldera, A., Meirelles, M.D.N., Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosonia cruzi (2004) Int J Antimicrob Agents, 23 (3), pp. 273-285
• Garzoni, L.R., Waghabi, M.C., Baptista, M.M., Antiparasitic activity of risedronate in a murine model of acute Chagas' disease (2004) Int J Antimicrob Agents, 23 (3), pp. 286-290
• Szajnman, S.H., Montalvetti, A., Wang, Y., Docampo, R., Rodriguez, J.B., Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase (2003) Bioorg Med Chem Lett, 13 (19), pp. 3231-3235
• Szajnman, S.H., Ravaschino, E.L., Docampo, R., Rodriguez, J.B., Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase (2005) Bioorg Med Chem Lett, 15 (21), pp. 4685-4690
• Docampo, R., Moreno, S.N., Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites (2001) Curr Drug Targets Infect Disord, 1 (1), pp. 51-61
• Gabelli, S.B., McLellan, J.S., Montalvetti, A., Oldfield, E., Docampo, R., Amzel, L.M., Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design (2006) Proteins, 62 (1), pp. 80-88
• Sigman, L., Sanchez, V.M., Turjansky, A.G., Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics (2006) J Mol Graph Model, 25 (3), pp. 345-352
• Mansour, T., (2002) Apellido, nombre, Ed, Chemotherapeutic targets in parasites: Contemporary strategies, pp. 90-122. , Cambridge University Press
• Gelb, M.H., Van Voohris, W.C., Buckner, F.S., Protein farnesyl and N-myristoyl transferases: Piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics (2003) Mol Biochem Parasitol, 126 (2), pp. 155-163
• Karp, J.E., Farnesyl transferase inhibition in hematologic malignancies (2005) J Natl Compr Canc Netw, 3 (1), pp. 37-40
• Esteva, M.I., Kettler, K., Maidana, C., Benzophenone-based farnesyl transferase inhibitors with high activity against Trypanosoma cruzi (2005) J Med Chem, 48 (23), pp. 7186-7191
• Field, M.C., Ali, B.R.S.: WO00105384A3 (2001); Windsor, W.T., Weber, P.C., Stricland, C., Syto, R., Girija-vallabhan, V.M., Kaminski, J.J., Guo, Z., US2003134846A1 2003; Krauth-Siegel, R.L., Inhoff, O., Parasite-specific trypanothione reductase as a drug target molecule (2003) Parasitol Res, 90 (2), pp. 77-85
• Krauth-Siegel, R.L., Bauer, H., Schirmar, R.H., Dithiol proteins as guardians of the intracellular redox milieu in parasites: Old and new drug targets in trypanosomes and malaria-causing plasmodia (2005) Angew Chem Int Ed Engl, 44 (5), pp. 690-715
• Augustins, K., Amssoms, K., Yamani, A., Rajan, P.K., Haemers, A., Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents (2001) Curr Pharm Des, 7 (12), pp. 1117-1141
• Stoppani, A.O., The chemotherapy of Chagas disease (1999) Medicina (Bs As), 59 (2), pp. 147-165
• Henderson, G.B., Ulrich, P., Fairlamb, A.H., Subversive substrates for the enzyme trypanothione disulfide reductase: Alternative approach to chemotherapy of Chagas disease (1988) Proc Natl Acad Sci USA, 85 (15), pp. 5374-5378
• Salmon Chemin, L., Buisine, E., Yardley, V., 2- and 3-substituted 1, 4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: Synthesis and correlation between redox cycling activities and in vitro cytotoxicity (2001) J Med Chem, 44 (4), pp. 548-565
• Blumenstiel, K., Schoeneck, R., Yardley, V., Croft, S.L., Krauth-Siegel, R.L., Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase (1999) Biochem Pharmacol, 58 (11), pp. 1791-1799
• Paulino, M., Iribarne, F., Dubin, M., Aguilera-Morales, S., Tapia, O., Stoppani, A.O., The chemotherapy of Chagas' disease: An overview (2005) Mini Rev Med Chem, 5 (5), pp. 499-519
• Santos, A.F., Ferraz, P.A., de Abreu, F.C., Chiari, E., Goulart, M.O., Sant'Ana, A.E., Molluscicidal and trypanocidal activities of lapachol derivatives (2001) Planta Med, 67 (1), pp. 92-93
• De Moura, K.C.G., Emery, F.S., Neves-Pinto, C., Synthesis and trypanocidal activity of naphthoquinones isolated from Tabebuia and heterocyclic derivatives: A review from an interdisciplinary study (2001) J Braz Chem Soc, 12, pp. 325-338
• Cuellar, M.A., Salas, C., Cortes, M.J., Morello, A., Diego Maya, J., Preite, M.D., Synthesis and in vitro trypanocide activity of several polycyclic drimane-quinone derivatives (2003) Bioorg Med Chem, 11 (12), pp. 2489-2497
• De Moura, K.C., Salomao, K., Menna-Barreto, R.F., Studies on the trypanocidal activity of semi-synthetic pyran [b-4, 3]naphtho [1,2-d]imidazoles from β-lapachone (2004) Eur J Med Chem, 39 (7), pp. 639-645
• Jorqueira, A., Goubea, R.M., Ferreira, V.F., Oxyrane derivative of alpha-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms (2006) Parasitol Res, 99 (4), pp. 429-433
• Silva, R.S., Costa, E.M., Trindade, U.L., Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi (2006) Eur J Med Chem, 41 (4), pp. 526-530
• Austin, S.E., Khan, M.O., Douglas, K.T., Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads (1999) Drug Des Discov, 16 (1), pp. 5-23
• Gallwitz, H., Bonse, S., Martinez-Cruz, A., Schichting, I., Schumacher, K., Krauth-Siegel, R.L., Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: Crystallographic, kinetic, and spectroscopic studies (1999) J Med Chem, 42 (3), pp. 364-372
• Farrell, N.P., Williamson, J., McLaren, D.J., Trypanocidal and antitumour activity of platinum-metal and platinum-metal-drug dual-fanction complexes (1984) Biochem Pharmacol, 33 (7), pp. 961-971
• Bonse S, Richards JM, Ross SA, Lowe G, Krauth-Siegel RL. (2, 2′: 6′, 2″-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase. J Med Chem 2000; 43(25): 4812-21; Sanchez-Delgado, R.A., Lazardi, K., Rincon, L., Urbina, J.A., Toward a novel metal-based chemotherapy against tropical diseases. Enhancement of the efficacy of clotrimazole against Trypanosoma cruzi by complexation to ruthenium in RuC12 (clotrimazole)2 (1993) J Med Chem, 36 (14), pp. 2041-2043
• Sanchez-Delgado, R.A., Anzellotti, A., Metal complexes as chemotherapeutic agents against tropical diseases: Trypanosomiasis, malaria and leishmaniasis (2004) Mini Rev Med Chem, 4 (1), pp. 23-30
• Lowe, G.: WO0050431A1 (2000); Lee, B., Bauer, H., Melchers, J., Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: A divinyl ketone as key intermediate (2005) J Med Chem, 48 (23), pp. 7400-7410
• Otelo, L., Vieites, M., Boiani, L., Novel trypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets (2006) J Med Chem, 49 (11), pp. 3322-3331
• Gutierrez-Correa, J., Fairlamb, A.H., Stoppani, A.O., Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals (2001) Free Radic Res, 34 (4), pp. 363-378
• Rivarola, H.W., Paglini Oliva, P., Trypanosoma cruzi trypanothione reductase inhibitors: Phenothiazines and related compounds modify experimental Chagas' disease evolution (2002) Curr Drug Targets Cardiovasc Haematol Disord, 2 (1), pp. 43-52
• Rivarola, H.W., Bustamante, J.M., Lo Presti, S., Trypanosoma cruzi: Chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area (2005) Exp Parasitol, 111 (2), pp. 80-86
• Jacoby, E.M., Schlichting, I., Lantwin, C.B., Kabsch, W., Krauth-Siegel, R.L., Crystal structure of the Trypanosoma cruzi trypanothione reductase-mepacrine complex (1996) Proteins, 24 (1), pp. 73-80
• Girault, S., Davioud-Charvet, E., Salmon, L., Berecibar, A., Debreu, M.A., Sergheraert, C., Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi (1998) Bioorg Med Chem Lett, 8 (10), pp. 1175-1180
• Girault, S., Davioud-Charvet, T.E., Maes, L., Potent and specific inhibitors of trypanothione reductase from Trypanosoma cruzi: Bis(2-aminodiphenylsulfides) for fluorescent labeling studies (2001) Bioorg Med Chem, 9 (4), pp. 837-846
• Bonnet, B., Soullez, D., Davioud-Charvet, E., Landry, V., Horvath, D., Sergheraert, C., New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase (1997) Bioorg Med Chem, 5 (7), pp. 1249-1256
• Li, Z., Fennie, M.W., Ganem, B., Polyamines with N-(3-phenylpropyl) substituents are effective competitive inhibitors of trypanothione reductase and trypanocidal agents (2001) Bioorg Med Chem Lett, 11 (2), pp. 251-254
• Flohe, L., Hecht, H.J., Steinert, T., Glutathione and trypanothione in parasitic hydroperoxide metabolism (1999) Free Radic Biol Med, 27 (9-10), pp. 966-984
• Fournet, A., Rojas de Arias, A., Ferreira, M.E., Efficacy of the bisbenzylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model (2000) Int J Antimicrob Agents, 13 (3), pp. 189-195
• Khan, M.O., Austin, S.E., Chan, C., Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines (2000) J Med Chem, 43 (16), pp. 3148-3156
• Parveen, S., Khan, M.O., Austin, S.E., Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide (2005) J Med Chem, 48 (25), pp. 8087-8097
• Aguirre, G., Cabrera, E., Cerecetto, H., Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti- Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design (2004) Eur J Med Chem, 39 (5), pp. 421-431
• Aguirre, G., Boiani, M., Cabrera, E., New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies (2006) Eur J Med Chem, 41 (4), pp. 457-466
• Meiering, S., Inhoff, O., Mies, J., Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis (2005) J Med Chem, 48 (15), pp. 4793-4802
• Wilkinson, S.R., Obado, S.O., Mauricio, I.L., Kelly, J.M., Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum (2002) Proc Natl Acad Sci USA, 99 (21), pp. 13453-13458
• Ravaschino, E.L., Docampo, R., Rodriguez, J.B., Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis (2006) J Med Chem, 49 (1), pp. 426-435
• Engel, J.C., Franke de Cazzulo, B.M., Stoppani, A.O., Cannata, J.J., Cazzulo, J.J., Aerobic glucose fermentation by Trypanosoma cruzi axenic culture amastigote-like forms during growth and differentiation to epimastigotes (1987) Mol Biochem Parasitol, 26 (1-2), pp. 1-10
• Souza, D.H., Garatt, R.C., Araujo, A.P., Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: Structure, catalytic mechanism and targeted inhibitor design (1998) FEBS Lett, 424 (3), pp. 131-135
• Aronov, A., Suresh, S., Buckner, F.S., Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase (1999) Proc Natl Acad Sci USA, 96 (8), pp. 4273-4278
• Bressi, J.C., Verlinde, C.L., Aronov, A.M., Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design (2001) J Med Chem, 44 (13), pp. 2080-2093
• Tomazela, D.M., Pupo, M.T., Passador, E.A., Pyrano chalcones and a flavone from Neoraputia magnifica and their Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase-inhibitory activities (2000) Phytochemistry, 55 (6), pp. 643-651
• Ladame, S., Castilho, M.S., Silva, C.H., Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1, 3-bisphospho-d-glyceric acid (2003) Eur J Biochem, 270 (22), pp. 4574-4586
• de Marchi, A.A., Castillo, M.S., Nascimento, P.G., New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi (2004) Bioorg Med Chem, 12 (18), pp. 4823-4833
• Hudock, M.P., Sanz-Rodriguez, C.E., Song, Y., Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates (2006) J Med Chem, 49 (1), pp. 215-223
• Maugeri, D.A., Cazzulo, J.J., The pentose phosphate pathway in Trypanosoma cruzi (2004) FEMS Microbiol Lett, 234 (1), pp. 117-123
• Igoillo-Esteve, M.I., Cazzulo, J.J., The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: Its role in the defense of the parasite against oxidative stress (2006) Mol Biochem Parasitol, 149 (2), pp. 170-181
• Pereira, C.A., Alonso, G.D., Paveto, M.C., Trypanosoma cruzi arginine kinase characterization and cloning. A novel energetic pathway in protozoan parasites (2000) J Biol Chem, 275 (2), pp. 1495-1501
• Pereira, C.A., Alonso, G.D., Ivaldi, S., Arginine metabolism in Trypanosoma cruzi is coupled to parasite stage and replication (2002) FEBS Lett, 526 (1-3), pp. 111-114
• Paveto, C., Guida, M.C., Esteva, M.I., Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins (2004) Antimicrob Agents Chemother, 48 (1), pp. 69-74
• Silber, A.M., Colli, W., Ulrich, H., Alves, M.J., Pereira, C.A., Amino acid metabolic routes in Trypanosoma cruzi: Possible therapeutic targets against Chagas' disease (2005) Curr Drug Targets Infect Disord, 5 (1), pp. 53-64
• Naula, C., Parsons, M., Mottram, J.C., Protein kinases as drug targets in Trypanosomes and Leishmania (2005) Biochim Biophys Acta, 1754 (1-2), pp. 151-159
• Braga, M.V., de Souza, W., Effects of protein kinase and phosphatidylinositol-3 kinase inhibitors on growth and ultrastructure of Trypanosoma cruzi (2006) FEMS Microbiol Lett, 256 (2), pp. 209-216
• Ariyanayagam, M.R., Fairlamb, A.H., Diamine auxotrophy may be a universal feature of Trypanosoma cruzi epimastigotes (1997) Mol Biochem Parasitol, 84 (1), pp. 111-121
• Majumder, S., Wirth, J.J., Bitonti, A.J., McCann, P.P., Kierszenbaum, F., Biochemical evidence for the presence of arginine decarboxylase activity in Trypanosoma cruzi (1992) J Parasitol, 78 (2), pp. 371-374
• Menezes D, Valentim C, Oliveira MF, Vannier-Santos MA Putrescine analogue cytotoxicity against Trypanosoma cruzi. Parasitol Research 2006; 98(2): 99-105; Audette, M., Charest-Gaudrealt, R., (2005), US6949679; Ullman, B., Carter, D., Molecular and biochemical studies on the hypoxanthine-guanine phosphoribosyltransferases of the pathogenic haemoflagellates (1997) Int J Parasitol, 27 (2), pp. 203-213
• Nakajima-Shimada, J., Hirota, Y., Aoki, T., Inhibition of Trypanosoma cruzi growth in mammalian cells by purine and pyrimidine analogs (1996) Antimicrob Agents Chemother, 40 (11), pp. 2455-2458
• Avila, J.L., Avila, A., Munoz, E., Effect of allopurinol on different strains of Trypanosoma cruzi (1981) Am J Trop Med Hyg, 30 (4), pp. 769-774
• Eakin, A.E., Guerra, A., Focia, P.J., Torres-Martinez, Craig, S.P., 3rd. Hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi as a target for structure-based inhibitor design: Crystallization and inhibition studies with purine analogs (1997) Antimicrob Agents Chemother, 41 (8), pp. 1686-1692
• Freymann, D.M., Wenck, M.A., Engel, J.C., Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi (2000) Chem Biol, 7 (12), pp. 957-968
• Wenck, M.A., Medrano, F.J., Eakin, A.E., Craig, S.P., Steady-state kinetics of the hypoxanthine phosphoribosyltransferase from Trypanosoma cruzi (2004) Biochim Biophys Acta, 1700 (1), pp. 11-18
• Reche, P., Arrebola, R., Santi, D.V., Gonzalez Pacanowska, D., Ruiz Perez, L.M., Expression and characterization of the Trypanosoma cruzi dihydrofolate reductase domain (1996) Mol Biochem Parasitol, 76 (1-2), pp. 175-185
• Gilbert, I.H., Inhibitors of dihydrofolate reductase in Leishmania and Trypanosomes (2002) Biochim Biophys Acta, 1587 (2-3), pp. 249-257
• Chowdhury, S.F., Guerrero, R.H., Brun, R., Ruiz-Perez, L., Pacanowska, D.G., Gilbert, I.H., Synthesis and testing of 5-benzyl-2, 4-diaminopyrimidines as potential inhibitors of leishmanial and trypanosomal dihydrofolate reductase (2002) J Enzyme Inhib Med Chem, 17 (5), pp. 293-302
• Pez, D., Leal, I., Zuccotto, F., 2,4-Diaminopyrimidines as inhibitors of Leishmanial and Trypanosomal dihydrofolate reductase (2003) Bioorg Med Chem, 11 (22), pp. 4693-4711
• Khabnadidesh, S., Pez, D., Musso, A., Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase (2005) Bioorg Med Cbem, 13 (7), pp. 2637-2649
• Sencovich, O., Bhatia, V., Garg, N., Chattopadhyay, D., Lipophilic antifolate trimetrexate is a potent inhibitor of Trypanosoma cruzi: Prospect for chemotherapy of Chagas' disease (2005) Antimicrob Agents Chemother, 49 (8), pp. 3234-3238
• Nare, B., Luba, J., Hardy, L.W., Beverley, S.M., New approaches to Leishmania chemotherapy: Pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity (1997) Parasitology, 114 (SUPPL.), pp. 101-110. , S
• Schormann, N., Pal, B., Chattopadhyay, D., Expression, purification, crystallization and preliminary crystallographic analysis of recombinant pteridine reductase of Trypanosoma cruzi (2001) Acta Crystallogr D Biol Crystallogr, 57 (11), pp. 1671-1673
• Senkovich, O., Pal, B., Schormann, N., Chattopadhyay, D., Trypanosoma cruzi genome encodes a pteridine reductase 2 protein (2003) Mol Biochem Parasitol, 127 (1), pp. 89-92
• Schormann, N., Pal, B., Senkovich, O., Cristal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor (2005) J Struct Biol, 152 (1), pp. 64-75
• Lowe, G.: WO0153276A1 (2001); Lawton, P., Purine analogs as antiparasitic agents (2005) Expert Opin Ther Patents, 15 (8), pp. 987-994
• Bottaro, J.C., Schmitt, R.J., Petrie, M.A., Penwell, P.E.: WO0114401A1 (2001); Nara, T., Kamei, Y., Tsubouchi, A., Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells (2005) Parasitol Internat, 54 (1), pp. 59-64
• Inaoka, D.K., Tashamira, E., Osanai, A., Expression, purification and crystallization of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with orotate (2005) Acta Crystal Sec F Struct Biol Cryst Commun, 61 (10), pp. 875-878
• Gonzales-Perdomo, M., de Castro, S.L., Meirelles, M.N., Goldenberg, S., Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors (1990) Antimicrob Agents Chemother, 34 (9), pp. 1707-1714
• Abdul-Rahman, S., (2005), US20056967205; Bodley, A.L., Shapiro, T.A., Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on Trypanosomes and Leishmania (1995) Proc Natl Acad Sci USA, 92 (9), pp. 3726-3730
• Stephens, C.E., Brun, R., Salem, M.M., The activity of diguandino and 'reversed' diamidino 2, 5-diarylfurans versus Trypanosoma cruzi and Leishmania donovani (2003) Bioorg Med Chem Lett, 13 (12), pp. 2065-2069
• Werbovetz, K., Diamidines as antitrypanosomal, antileishmanial and antimalarial agents (2006) Curr Opin Invest Drugs, 7 (2), pp. 147-157
• Boykin, D., Tlidwell, R.R., Wilson, W.D., Perfect, J.R., Stephens, C.E.: WO02057224A2 and WO02057224A3 (2002); Ochola, D.O., Prichard, R.K., Lubega, G.W., Classical ligands bind tubulin of trypanosomes and inhibit their growth in vitro (2002) J Parasitol, 88 (3), pp. 600-604
• Werbovetz, K., Bhatta Charya, G., Sackett, D., Salem, M.M.: WO03090678A2 and WO03090678A3 (2003); Bukrinsky, M.I., Cerami, A., Ulrich, P., Berger, B., (2005), US20056906076; Docampo, R., de Souza, W., Miranda, K., Rohloff, P., Moreno, S.N., Acidocalcisomes-conserved from bacteria to man (2005) Nat Rev Microbiol, 3 (3), pp. 251-261
• Lang, H.J., Lanzer, M., Wiesner, J., Sanchez, C., Wunsch, S.E.P., (2000), US20006114393; Menna-Barreto, R.F., Henriquez-Pons, A., Pinto, A.V., Morgado-Diaz, J.A., Soares, M.J., De Castro, S.L., Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: Identification of target organelles (2005) J Antimicrob Chemother, 56 (6), pp. 1034-1041
• Montalvetti, A., Rohloff, P., Docampo, R.A., A functional aquaporin co-localizes with the vacuolar proton pyrophosphatase to acidocalcisomes and the contractile vacuole complex of Trypanosoma cruzi (2004) J Biol Chem, 279 (37), pp. 38673-38682
• Beitz, E., Aquaporins from pathogenic protozoan parasites: Structure, function and potential for chemotherapy (2005) Biol Cell, 97 (6), pp. 373-383
• Wilkinson, S.R., Prathalingam, S.R., Taylor, M.C., Horn, D., Kelly, J.M., Vitamin C biosynthesis in trypanosomes: A role for the glycosome (2005) Proc Natl Acad Sci USA, 102 (33), pp. 11645-11650
• Schenkman, S., Chaves, L.B., Pontes de Carvalho, L.C., Eichinger, D., A proteolytic fragment of Trypanosoma cruzi trans-sialidase lacking the carboxyl-terminal domain is active, monomeric, and generates antibodies that inhibit enzymatic activity (1994) J Biol Chem, 269 (11), pp. 7970-7975
• Frasch, A.C., Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi (2000) Parasitol Today, 16 (7), pp. 282-286
• Buschiazzo, A., Amaya, M.F., Cremona, M.L., Frasch, A.C., Alzari, P.M., The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis (2002) Mol Cell, 10 (4), pp. 757-768
• Streicher, H., Busse, H., Building a successful structural motif into sialylmimetics-cyclohexenephosphonate monoesters as pseudo-sialosides with promising inhibitory properties (2006) Bioorg Med Chem, 14 (4), pp. 1047-1057
• Horenstein, B.A., Parr, I.B.: WO9906369A1 (1999); Luo, M., White, C.L., (2000), US20006114386; Santa Rita SM, Santos Barboza H, Meirelles MN, de Castro SL. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi. Acta Tropics 2000; 75(2): 219-28; Lira, R., Contreras, L.M., Rita, R.M., Urbina, J.A., Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: Potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole (2001) J Antimicrob Chemother, 47 (5), pp. 537-546
• de Castro, S.L., Santa Rita, R.M., Urbina, J.A., Croft, S.L., Antiprotozoal lysophospholipid analogues: A comparison of their activity against trypanosomatid parasites and tumor cells (2004) Mini Rev Med Chem, 4 (2), pp. 141-151
• Santa Rita, R.M., Lira, R., Barbosa, H.S., Urbina, J.A., de Castro, S.L., Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis (2005) J Antimicrob Chemother, 55 (5), pp. 780-784
• Santa Rita, R.M., Barbosa, H.S., de Castro, S.L., Ultrastructural analysis of edelfosine-treated trypomastigotes and amastigotes of Trypanosoma cruzi (2006) Parasitol Res, 100 (1), pp. 189-190
• Jones, S.M., Urch, J.E., Brun, R., Harwood, J.L., Berry, C., Gilbert, I.H., Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents (2004) Bioorg Med Chem, 12 (4), pp. 683-692
• Couto, A.S., Caffaro, C., Uhrig, M.L., Glycosphingolipids in Plasmodium falciparum. Presence of an active glucosylceramide synthase (2004) Eur J Biochem, 271 (11), pp. 2204-2214
• Pankova-Kholmyansky, I., Flescher, E., Potential new antimalarials chemotherapeutics based on sphingolipid methabolism (2006) Chemotherapy, 52, pp. 205-209
• Solari, A.J., Duschak, V.G., Intermediate filaments induced by Taxol in cultures of Crithidia fasciculata (1985) Microscopía Electrónica y Biología Celular, 9 (2), pp. 163-175
• Dantas, A.P., Barbosa, H.S., De Castro, S.L., Biological and ultrastructural effects of the anti-microtubule agent taxol against Trypanosoma cruzi (2003) J Submicrosc Cytol Pathol, 35 (3), pp. 287-294
• Grellier, P., Sinou, V., Garreau-de Loubresse, N., Bylen, E., Boulard, Y., Schrevel, J., Selective and reversible effects of vinca alkaloids on Trypanosoma cruzi epimastigote forms: Blockage of cytokinesis without inhibition of the organelle duplication (1999) Cell Motil Cytoskeleton, 42 (1), pp. 36-47
• Morello, A., Lipchenka, I., Cassels, B.K., Speisky, H., Aldunate, J., Repetto, Y., Trypanocidal effect of boldine and related alkaloids upon several strains of Trypanosoma cruzi (1994) Comp Biochem Physiol Pharmacol Toxicol Endocrinol, 107 (3), pp. 367-371
• Rivas, P., Cassels, B.K., Morello, A., Repetto, Y., Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes (1999) Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 122 (1), pp. 27-31
• Chataing, B., Concepcion, J.L., Lobaton, R., Usubillaga, A., Inhibition of Trypanosoma cruzi growth in vitro by Solanum alkaloids: A comparison with ketoconazole (1998) Planta Med, 64 (1), pp. 31-36
• Mahiou, V., Roblot, F., Fournet, A., Hocquemiller, R., isbenzylisoquinoline alkaloids from Guatteria boliviana (Annonaceae) (2000) Phytochemistry, 54 (7), pp. 709-716
• Ribeiro, T.S., Freire de Lima, L., Previato, J.O., Mendonca Previato, L., Heise, N., de Lima, M.E., Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi (2004) Bioorg Med Chem Lett, 14 (13), pp. 3555-3558
• Gonzalez, P., Marin, C., Rodriguez-Gonzalez, I., Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American trypanosomiasis (2006) Pharmacology, 76 (3), pp. 123-128
• del Olmo, E., Armas, M.G., Lopez-Perez, J.L., Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds (2001) Bioorg Med Chem Lett, 11 (20), pp. 2755-2757
• Bronia, D.H., Pereira, B.M., Lujan, H.D., Fretes, R.E., Fernández, A., Paglini, P.A., Ganglioside treatment of acute Trypanosoma cruzi infection in mice promotes long-term survival and parasitological cure (1999) Ann Trop Med Parasitol, 93 (4), pp. 341-350
• Fernández Gomez, R., Zerrouk, H., Sebti, F., Loyens, M., Benslimane, A., Ouaissi, M.A., Growth inhibition of Trypanosoma cruzi and Leishmania donovani infantum by different snake venoms: Preliminary identification of proteins from Cerastes cerastes venom which interact with the parasites (1994) Toxicon, 32 (8), pp. 875-882
• Stoka, A.M., Activity of juvenile hormone and juvenile hormone analogues on the growth of Trypanosoma cruzi (1996) J Steroid Biochem Mol Biol, 59 (5-6), pp. 495-500
• Fichera L, Esteva M, Wimmer Z, Rodríguez JB, Gros EG. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi. Z Naturforsch [C] 1995; 50(7-8): 578-80; Rodriguez, J.B., Docampo, R., Gros, E.G., Sulphur-containing derivatives structurally related to fenoxycarb are potent growth inhibitors against the intracellular form of Trypanosoma cruzi (2000) Int J Antimicrob Agents, 13 (3), pp. 215-218
• Esteva, M., Ruiz, A.M., Stoka, A.M., Trypanosoma cruzi: Methoprene is a potent agent to sterilize blood infected with trypomastigotes (2002) Exp Parasitol, 100 (4), pp. 248-251
• Weniger, B., Vonthron-Senecheau, C., Kaiser, M., Brun, R., Anton, R., Comparative antiplasmodial, leishmanicidal and trypanocidal activities of several biflavonoids (2006) Phytomedicine, 13 (3), pp. 176-180
• de Castro, Higashi KO. Effect of different formulations of propolis on mice infected with Trypanosoma cruzi. J Ethnopharmacol 1995; 46(1): 55-58; Marcuchi, M.C., Ferreres, F., Garcia-Viguera, C., Phenolic compounds from Brazilian propolis with pharmacological activities (2001) J Ethnopharmacol, 74 (2), pp. 105-112
• Prytzyk, E., Dantas, A.P., Salomao, K., Flavonoids and trypanocidal activity of Bulgarian propolis (2003) J Ethnopharmacol, 88 (2-3), pp. 189-193
• da Silva Cunha, I.B., Salomao, K., Shimizu, M., Antitrypanosomal activity of Brazilian propolis from Apis mellifera (2004) Chem Pharm Bull (Tokyo), 52 (5), pp. 602-604
• Dantas, A.P., Olivieri, B.P., Gomez, F.H., De Castro, S.L., Treatment of Trypanosoma cruzi-infected mice with propolis promotes changes in the immune response (2006) J Ethnopharmacol, 103 (2), pp. 187-193
• De Castro, S.L., Pinto, M.C., Pinto, A.V., Screening of natural and synthetic drugs against Trypanosoma cruzi. 1. Establishing a structure/ activity relationship (1994) Microbios, 78 (315), pp. 83-90
• Morello, A., Pavani, M., Garbarino, J.A., Effects and mode of action of 1, 4-naphthoquinones isolated from Calceolaria sessilis on tumoral cells and Trypanosoma parasites (1995) Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 112 (2), pp. 119-128
• Alves, T.M., Alves, R., Romanha, A.J., Zani, C.L., dos Santos, M.H., Nagem, T.J., Biological activities of 7-epiclusianone (1999) J Nat Prod, 62 (2), pp. 369-371
• Bell, A., Monaghan, P., Page, A.P., Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action (2006) Int J Parasitol, 36 (3), pp. 261-276
• Bua, J., Ruiz, A.M., Potenza, M., Fichera, L.E., in vitro Anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi (2004) Bioorg Med Chem Lett, 14 (18), pp. 4633-4637
• Fournet, A., Barrios, A.A., Munoz, V., Leishmanicidal and trypanocidal activities of Bolivian medicinal plants (1994) J Ethnopharmacol, 41 (1-2), pp. 19-37
• Berger, I., Passreiter, C.M., Caceres, A., Kukelka, W., Antiprotozoal activity of Neurolaena lobata (2001) Phytother Res, 15 (4), pp. 327-330
• Muelas-Serrano, S., Nogal, J.J., Martinez-Diaz, R.A., Escario, J.A., Martinez-Fernandez, A.R., Gomez-Barrio, A., in vitro Screening of American plant extracts on Trypanosoma cruzi and Trichomonas vaginalis (2000) J Ethnopharmacol, 71 (1-2), pp. 101-107
• Mafezoli, J., Vieira, P.C., Fernandez, J.B., da Silva, M.F., de Albuquerque, S., in vitro Activity of Rutaceae species against the trypomastigote form of Trypanosoma cruzi (2000) J Ethnopharmacol, 73 (1-2), pp. 335-340
• Pizzolatti, M.G., Koga, A.H., Grisard, E.C., Steindel, M., Trypanocidal activity of extracts from Brazilian Atlantic Rain Forest plant species (2003) Phytomedicine, 10 (5), pp. 422-426
• Truiti, M.C., Ferreira, I.C., Zamuner, M.L., Nakamura, C.V., Serragiotto, M.H., Souza, M.C., Antiprotozoal and molluscicidal activities of five Brazilian plants (2005) Braz J Med Biol Res, 38 (12), pp. 1873-1878
• Mesquita, M.L., Desrivot, J., Bories, C., Antileishmanial and trypanocidal activity of Brazilian Cerrado plants (2005) Mem Inst Oswaldo Cruz, 100 (7), pp. 783-787
• Abe, F., Nagafuji, S., Yamauchi, T., Trypanocidal constituents in plants 1. Evaluation of some Mexican plants for their trypanocidal activity and active constituents in Guaco, roots of Aristolochia taliscana (2002) Biol Pharm Bull, 25 (9), pp. 1188-1191
• Sulsen, V., Guida, C., Coussio, J., Paveto, C., Muschietti, L., Martino, V., in vitro Evaluation of trypanocidal activity in plants used in Argentine traditional medicine (2006) Parasitol Res, 98 (4), pp. 370-374
• Waechter, A.I., Cave, A., Hocquemiller, R., Bories, C., Munoz, V., Fournet, A., Antiprotozoal activity of aporphine alkaloids isolated from Unonopsis buchtienii (Annonaceae) (1999) Phytother Res, 13 (2), pp. 175-177
• Fevrier, A., Ferreira, M.E., Fournet, A., Acetogenins and other compounds from Rollinia emarginata and their antiprotozoal activities (1999) Planta Med, 65 (1), pp. 47-49
• Schmeda-Hirschmann, G., Astudillo, L., Bastida, J., Cryptofolione derivatives from Cryptocarya alba fruits (2001) J Pharm Pharmacol, 53 (4), pp. 563-567
• Bonay, P., Duran-Chica, I., Fresno, M., Alarcon, B., Alcina, A., Antiparasitic effects of the intra-Golgi transport inhibitor megalomicin (1998) Antimicrob Agents Chemother, 42 (10), pp. 2668-2673
• Rolon, M., Seco, M.N., Vega, C., Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi (2006) Int J Antimicrob Agents, 28 (2), pp. 104-109
• Bastos, J.K., Albuquerque, S., Silva, M.L., Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo (1999) Planta Med, 65 (6), pp. 541-544
• Luize, P.S., Ueda-Nakamura, T., Filho, B.P., Ultrastructural alterations induced by the neolignan eupomatenoid-5 on epimastigote and amastigote forms of Trypanosoma cruzi (2006) Parasitol Res, 29 (10), pp. 2126-2130
• Tasdemir, D., Kaiser, M., Brun, R., Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies (2006) Antimicrob Agents Chemother, 50 (4), pp. 1352-1364
• Batista, R., Chiari, E., de Oliveira, A.B., Trypanosomicidal kaurane diterpenes from Wedelia paludosa (1999) Planta Med, 65 (3), pp. 283-284
• Araya, J.E., Neira, I., da Silva, S., Diterpenoids from Azorella compacta (Umbelliferae) active on Trypanosoma cruzi (2003) Mem Inst Oswaldo Cruz, 98 (3), pp. 413-418
• Kiuchi, F., Matsuo, K., Ito, M., Qui, T.K., Honda, G., New norditerpenoids with trypanocidal activity from Vitex trifolia (2004) Chem Pharm Bull (Tokyo), 52 (12), pp. 1492-1494
• Uchiyama, N., Kabututu, Z., Kubata, B.K., Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme (2005) Antimicrob Agents Chemother, 49 (12), pp. 5123-5126
• Rubio J, Calderon JS, Flores A, Castro AC, Cespedes CL. Trypanocidal activity of oleoresin and terpenoids isolated from Pinus oocarpa. Z Naturforsch [C]. 2005; 60(9-10): 711-16; Sanchez, A.M., Jimenez Ortiz, V., Sartor, T., A novel icetexane diterpene, 5-epi-icetexone from Salvia gilliessi is active against Trypanosoma cruzi (2006) Acta Tropica, 98 (2), pp. 118-124
• Campos, F.R., Januario, A.H., Rosas, L.V., Trypanocidal activity of extracts and fractions of Bertholletia excelsa (2005) Fitoterapia, 76 (1), pp. 26-29
• Saednia S, Gohary AR, Ito M, Kiuchi F, Honda G. Bioactive constituents from Dracocephalum subcapitatum (O. Kuntze) Lipsky. N Naturforsch 2005; 60(1-2): 22-24; Cunha, W.R., Crevelin, E.J., Arantes, G.M., A study of the trypanocidal activity of triterpene acids isolated from Miconia species (2006) Phytother Res, 20 (6), pp. 474-478
• Brengio, S.D., Belmonte, S.A., Guerreiro, E., Giordano, O.S., Pietrobon, E.O., Sosa, M.A., The sesquiterpene lactone dehydroleucodine affects the growth of cultured epimastigotes of Trypanosoma cruzi (2000) J Parasitol, 86 (2), pp. 407-412
• Schmidt, A., Kraugh-Siegel, R.L., Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development (2002) Curr Top Med Chem, 2 (11), pp. 1239-1259
• Jimenez-Ortiz, V., Brengio, S.D., Giordano, O., The trypanocidal effect of sesquiterpene lactones helenalin and mexicanin on cultured epimastigotes (2005) J Parasitol, 91 (1), pp. 170-174
• Jordao CO, Vichenewsky W, de Souza GE, Albuquerque S, Lopes JL. Trypanocidal activity of chemical constituents from Lychnophora salicifolia. Mart. Phytother Res 2004; 18(4): 332-34; Kiuchi, F., Matsuo, K., Ito, M., Qui, T.K., Honda, G., New sesquiterpene hydroperoxides with trypanocidal activity from Pogostemon cablin (2004) Chem Pharm Bull (Tokyo), 52 (12), pp. 1495-1496
• Grael, C.F., Albuquerque, S., Lopez, J.L., Chemical constituents of Lychnophora pohlii and trypanocidal activity of crude plant extracts and of isolated compounds (2005) Fitoterapia, 76 (1), pp. 73-82
• Orhan, I., Sener, B., Atici, T., Brun, R., Perozzo, R., Tasdemir, D., Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis (2006) Phytomedicine, 13 (6), pp. 388-393
• Bringmann, G., Rummey, C., Neumann, S., Brun, R., Stich, A., Hoerr, V., Mueller, W.E.G.: WO04067514A1 (2004); Bringmann, G., Pfeifer, R.M., Brun, R., Muller, W.E.G.: WO04065349 ( 2004); Bringman, G., Hamm, A., Gunther, C., Michel, M., Brun, R., Mudogo, V., Ancistroealaines A and B, two new bioactive naphthyl-isoquinolines, and related naphthoic acids from Ancistrocladus ealaensis (2000) J Nat Prod, 63 (11), pp. 1465-1470
• Buske, A., Kekule, A.S., Haring, A., Adam, G.: WO0300272A1 (2003); Ferreira, M.E., Fournet, A., Rojas de Arias, A., Hocquemiller, R., Poupon, E.: WO04050092 A1 and WO04050092 B1 (2004); Silva, M.L.A., Albuquerque, S., Souza, G.E.B., Bastos, J.K., Silva, R.: WO03080600A1 (2003); De Souza, V.A., da Silva, R., Pereira, A.C., Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi (2005) Bioorg Med Chem Lett, 15 (2), pp. 303-307
• Cerecetto, H., Gonzalez, M., Chemotherapy of Chagas' disease: Status and new developments (2002) Curr Top Med Chem, 2 (11), pp. 1187-1213
• Ren, H., Grady, S., Banhart, M., Synthesis and in vitro anti-protozoal activity of a series of benzotropolone derivatives incorporating endocyclic hydrazines (2003) Eur J Med Chem, 38 (12), pp. 949-957
• Carvalho, S.A., da Silva, E.F., Santa-Rita, R.M., de Castro, S.L., Fraga, C.A., Synthesis and antitrypanosomal profile of new functionalized 1, 3, 4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues (2004) Bioorg Med Chem Lett, 14 (24), pp. 5967-5970
• De Souza, E.M., Lansiaux, A., Bailly, C., Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma Cruzi and Leishmania amazonensis (2004) Biochem Pharmacol, 68 (4), pp. 593-600
• De Souza, E.M., Mena-Barretto, R., Araujo-Jorge, T.C., Antiparasitic activity of aromatic diamidines is related to apoptosis-like death in Trypanosoma cruzi (2006) Parasitology, 133 (1), pp. 75-79
• Baliani, A., Buene, G.J., Stewart, M.L., Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites (2005) J Med Chem, 48 (17), pp. 5570-5579
• Molfetta, F.A., Bruni, A.T., Honorio, K.M., da Silva, A.B., A structure-activity relationship study of quinone compounds with trypanocidal activity (2005) Eur J Med Chem, 40 (4), pp. 329-338
• Aguirre, G., Boiani, L., Cerecetto, H., In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi 5-nitrofuryl containing thiosemicarbazones (2004) Bioorg Med Chem, 12 (18), pp. 4885-4893
• Aguirre, G., Cerecetto, H., Di Maio, R., Quinoxaline N, N′-dioxide derivatives and related compounds as growth inhibitors of T. cruzi. Structure-activity relationships (2004) Bioorg Med Chem, 14 (14), pp. 3835-3839
• Aguirre, G., Boiani, L., Cerecetto, H., 1, 2-c] 1, 2, 5-oxadiaxole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds (2005) Bioorg Med Chem, 13 (23), pp. 6324-6335
• Aguirre G, Boiani L, Boiani M, et al.. New potent 5-substituted benzofuroxans as inhibitors of [Trypanosoma cruzi growth: quantitative structure-activity relationship studies Bioorg Med Chem 2005; 13 (23): 6336-46; Oliviera, D.A., Pereira, D.G., Fernandes, A.M., Trypanocidal activity of 2-propen-1-amine derivatives on trypomastigotes culture and in animal model (2005) Parasitol Res, 95 (3), pp. 161-166
• Gerpe, A., Aguirre, G., Boiani, L., Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies (2006) Bioorg Med Chem, 14 (10), pp. 3467-3480
• Boiani, M., Boiani, L., Denicola, A.J., 2H-benzimidazole 1,3-dioxide derivatives: A new family of water-soluble anti-trypanosomatid agents (2006) J Med Chem, 49 (11), pp. 3215-3224
• De Fatima, A., Marquissolo, C., de Albuquerque, S., Carraro Abrahao, A.A., Pilli, R.A., Trypanocidal activity of 5, 6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi (2006) Eur J Med. Chem, 41 (10), pp. 1210-1213
• Montero Torres, A., Vega, M.C., Marrero Ponce, Y., (2005) A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal, 13 (22), pp. 6264-6275. , compounds
• Vega, M.C., Montero Torres, A., Marrero Ponce, Y., New ligand-based approach for the discovery of antitrypanosomal compounds (2006) Bioorg Med Chem Lett, 16 (7), pp. 1898-1904
• Sas, B., Van Hemel, J., Vanderkerckhove, J.: WO04062590A2 and WO04062590A3 (2004); Duran Caballero, N.E., Duran Haun, M.A., De Conti Lourenco, R.M., De Souza, A.O., Haun Quiros, N.M.: BR09805381A (2000); Ahlem, C.N., Frincke, J.M., Prendergast, P.T., (2000) WO0032201A2 and WO0032201A3
• Wyvratt, M.J., Biftu, T., Fisher, M.H., Schmatz, D.M.: WO04080390A2 and WO04080390A3 (2004); Dardonville C. Recent advances in antitrypanosomal chemotherapy: patent literature 2002-2004.Expert opinion Ther Patents 2005; 15(9): 1241-57

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------